Management of the chronic hepatitis B carrier

Chronic hepatitis B is an increasingly prevalent disease in Australia, both because of inadequacies of the current vaccination program, and because of changing population demographics. Regular follow-up of these patients is indicated, particularly as we now have effective anti viral therapy available. The unfavourable disease outcome in about 30% of hepatitis B carriers warrants increased recognition and observation of this group of patients.